1-3 of 3
Keywords: lung squamous cell carcinoma
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Articles

Correction: Silencing GOLGA8B inhibits cell invasion and metastasis by suppressing STAT3 signaling pathway in lung squamous cell carcinoma

Open Access
Journal: Clinical Science
Clin Sci (Lond) (2024) 138 (16): 987.
https://doi.org/10.1042/CS-2022-0128_COR
Published: 09 August 2024
... © 2024 The Author(s). 2024 This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY) . GOLGA8B lung squamous cell carcinoma metastasis STAT3 The authors...
View articletitled, Correction: Silencing GOLGA8B inhibits cell invasion and metastasis by suppressing STAT3 signaling pathway in lung squamous cell carcinoma
Open the PDF for Correction: Silencing GOLGA8B inhibits cell invasion and metastasis by suppressing STAT3 signaling pathway in lung squamous cell carcinoma in another window
Articles

Silencing GOLGA8B inhibits cell invasion and metastasis by suppressing STAT3 signaling pathway in lung squamous cell carcinoma

Available to Purchase
Zhanzhan Li, Yanyan Li, Na Li, Liangfang Shen, Aibin Liu
Journal: Clinical Science
Clin Sci (Lond) (2022) 136 (11): 895–909.
https://doi.org/10.1042/CS20220128
Published: 06 June 2022
...Zhanzhan Li; Yanyan Li; Na Li; Liangfang Shen; Aibin Liu Changes to some Golgi subfamily member proteins are reported to be involved in tumor metastasis. However, the functional role and potential mechanism of the Golgi A8 family member B (GOLGA8B) in lung squamous cell carcinoma (LUSC) remains...
View articletitled, Silencing GOLGA8B inhibits cell invasion and metastasis by suppressing STAT3 signaling pathway in lung squamous cell carcinoma
Open the PDF for Silencing GOLGA8B inhibits cell invasion and metastasis by suppressing STAT3 signaling pathway in lung squamous cell carcinoma in another window
Includes: Supplementary data
Articles

Gemcitabine resistance mediated by ribonucleotide reductase M2 in lung squamous cell carcinoma is reversed by GW8510 through autophagy induction

Available to Purchase
Ping Chen, Jian-Nong Wu, Yang Shu, He-Guo Jiang, Xiao-Hui Zhao, Hai Qian, Kang Chen, Ting Lan, Chen-Guo Chen, Jian Li
Journal: Clinical Science
Clin Sci (Lond) (2018) 132 (13): 1417–1433.
https://doi.org/10.1042/CS20180010
Published: 09 July 2018
...Ping Chen; Jian-Nong Wu; Yang Shu; He-Guo Jiang; Xiao-Hui Zhao; Hai Qian; Kang Chen; Ting Lan; Chen-Guo Chen; Jian Li Although chemotherapeutic regimen containing gemcitabine is the first-line therapy for advanced lung squamous cell carcinoma (LSCC), gemcitabine resistance remains an important...
View articletitled, Gemcitabine resistance mediated by ribonucleotide reductase M2 in lung squamous cell carcinoma is reversed by GW8510 through autophagy induction
Open the PDF for Gemcitabine resistance mediated by ribonucleotide reductase M2 in lung squamous cell carcinoma is reversed by GW8510 through autophagy induction in another window
Includes: Supplementary data